<HashMap><database>biostudies-literature</database><scores><citationCount>0</citationCount><reanalysisCount>0</reanalysisCount><viewCount>60</viewCount><searchCount>0</searchCount></scores><additional><submitter>Sluchanko NN</submitter><funding>Wellcome Trust</funding><pagination>12014</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5607241</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>7(1)</volume><pubmed_abstract>In eukaryotes, several "hub" proteins integrate signals from different interacting partners that bind through intrinsically disordered regions. The 14-3-3 protein hub, which plays wide-ranging roles in cellular processes, has been linked to numerous human disorders and is a promising target for therapeutic intervention. Partner proteins usually bind via insertion of a phosphopeptide into an amphipathic groove of 14-3-3. Structural plasticity in the groove generates promiscuity allowing accommodation of hundreds of different partners. So far, accurate structural information has been derived for only a few 14-3-3 complexes with phosphopeptide-containing proteins and a variety of complexes with short synthetic peptides. To further advance structural studies, here we propose a novel approach based on fusing 14-3-3 proteins with the target partner peptide sequences. Such chimeric proteins are easy to design, express, purify and crystallize. Peptide attachment to the C terminus of 14-3-3 via an optimal linker allows its phosphorylation by protein kinase A during bacterial co-expression and subsequent binding at the amphipathic groove. Crystal structures of 14-3-3 chimeras with three different peptides provide detailed structural information on peptide-14-3-3 interactions. This simple but powerful approach, employing chimeric proteins, can reinvigorate studies of 14-3-3/phosphoprotein assemblies, including those with challenging low-affinity partners, and may facilitate the design of novel biosensors.</pubmed_abstract><journal>Scientific reports</journal><pubmed_title>Chimeric 14-3-3 proteins for unraveling interactions with intrinsically disordered partners.</pubmed_title><pmcid>PMC5607241</pmcid><funding_grant_id>101528</funding_grant_id><funding_grant_id>098230</funding_grant_id><funding_grant_id>206377/Z/17/Z</funding_grant_id><pubmed_authors>Sluchanko NN</pubmed_authors><pubmed_authors>Antson AA</pubmed_authors><pubmed_authors>Greive SJ</pubmed_authors><pubmed_authors>Tugaeva KV</pubmed_authors><view_count>60</view_count></additional><is_claimable>false</is_claimable><name>Chimeric 14-3-3 proteins for unraveling interactions with intrinsically disordered partners.</name><description>In eukaryotes, several "hub" proteins integrate signals from different interacting partners that bind through intrinsically disordered regions. The 14-3-3 protein hub, which plays wide-ranging roles in cellular processes, has been linked to numerous human disorders and is a promising target for therapeutic intervention. Partner proteins usually bind via insertion of a phosphopeptide into an amphipathic groove of 14-3-3. Structural plasticity in the groove generates promiscuity allowing accommodation of hundreds of different partners. So far, accurate structural information has been derived for only a few 14-3-3 complexes with phosphopeptide-containing proteins and a variety of complexes with short synthetic peptides. To further advance structural studies, here we propose a novel approach based on fusing 14-3-3 proteins with the target partner peptide sequences. Such chimeric proteins are easy to design, express, purify and crystallize. Peptide attachment to the C terminus of 14-3-3 via an optimal linker allows its phosphorylation by protein kinase A during bacterial co-expression and subsequent binding at the amphipathic groove. Crystal structures of 14-3-3 chimeras with three different peptides provide detailed structural information on peptide-14-3-3 interactions. This simple but powerful approach, employing chimeric proteins, can reinvigorate studies of 14-3-3/phosphoprotein assemblies, including those with challenging low-affinity partners, and may facilitate the design of novel biosensors.</description><dates><release>2017-01-01T00:00:00Z</release><publication>2017 Sep</publication><modification>2024-12-04T12:53:54.008Z</modification><creation>2019-03-27T02:56:57Z</creation></dates><accession>S-EPMC5607241</accession><cross_references><pubmed>28931924</pubmed><doi>10.1038/s41598-017-12214-9</doi></cross_references></HashMap>